Serum Phosphorus and Pill Burden Among Hemodialysis Patients Prescribed Sucroferric Oxyhydroxide: One-Year Follow-Up on a Contemporary Cohort

PURPOSE: In prior analyses of real-world cohorts of hemodialysis patients switched from one phosphate binder (PB) to sucroferric oxyhydroxide (SO), SO therapy has been associated with improvements in serum phosphorus (sP) and reductions in daily PB pill burden. To characterize how SO initiation patt...

Descripción completa

Detalles Bibliográficos
Autores principales: Kendrick, Jessica B, Zhou, Meijiao, Ficociello, Linda H, Parameswaran, Vidhya, Mullon, Claudy, Anger, Michael S, Coyne, Daniel W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012313/
https://www.ncbi.nlm.nih.gov/pubmed/35431567
http://dx.doi.org/10.2147/IJNRD.S353213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012313/
https://www.ncbi.nlm.nih.gov/pubmed/35431567
http://dx.doi.org/10.2147/IJNRD.S353213

Ejemplares similares